TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biotage Sweden AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
483,103
|
582,956
|
557,684 |
| Financial expenses |
1
|
20,065
|
4,737 |
| Earnings before taxes |
125,480
|
157,577
|
136,318 |
| EBITDA |
121,121
|
179,471
|
143,879 |
| Total assets |
451,746
|
387,631
|
395,862 |
| Current assets |
444,914
|
379,933
|
385,455 |
| Current liabilities |
172,980
|
178,005
|
153,303 |
| Equity capital |
272,870
|
204,338
|
230,686 |
| - share capital |
2,597
|
2,584
|
2,812 |
| Employees (average) |
92
|
93
|
95 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
60.4%
|
52.7%
|
58.3% |
| Turnover per employee |
5,251
|
6,268
|
5,870 |
| Profit as a percentage of turnover |
26.0%
|
27.0%
|
24.4% |
| Return on assets (ROA) |
27.8%
|
45.8%
|
35.6% |
| Current ratio |
257.2%
|
213.4%
|
251.4% |
| Return on equity (ROE) |
46.0%
|
77.1%
|
59.1% |
| Change turnover |
-102,856
|
70,445
|
37,454 |
| Change turnover % |
-18%
|
14%
|
7% |
| Chg. No. of employees |
-1
|
-2
|
-2 |
| Chg. No. of employees % |
-1%
|
-2%
|
-2% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.